Assignee
NEURODAWN PHARMACEUTICAL CO LTD
CN·0 granted patents·5 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
5 records- 0157US2025057832A1Use of a class of 1,4-dihydro-naphthyridine derivatives in treatment of tumorsNEURODAWN PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0255US2024335407A1Pharmaceutical composition and use thereofNEURODAWN PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0354US2024165087A1Application of riluzole- and borneol-containing composition in preparation of medication for treating cerebrovascular diseasesNEURODAWN PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0453US2024122917A1Use of composition containing cilostazol in cerebrovascular diseasesNEURODAWN PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0553US2024082234A1Application of cilostazol-containing composition in preparing drug for treating cerebrovascular diseaseNEURODAWN PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEURODAWN PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →